Category Archives: Type 1 diabetes

Geron Bolsters Extensive Embryonic Stem Cell Patent Estate

Geron yesterday announced the issuance of US patent #7,326,572, helping to extend their patent protection around their embryonic stem (ES) cell platform technology in the area of treating type 1 diabetes. Currently, Geron owns an exclusive license from the Wisconsin … Continue reading

Advertisement

Posted in Embyonic Stem Cells, Geron, Intellectual Property, Novocell, Regenerative Medicine, Type 1 diabetes | Tagged , , , | Leave a comment